Literature DB >> 26900773

The impact of anxiety, seizure severity, executive dysfunction, subjectively perceived psychological deficits, and depression on social function in patients with epilepsy.

Christina Kampf1, Uwe Walter2, Johannes Rösche3.   

Abstract

The impact of anxiety, seizure severity, executive dysfunction, subjectively perceived psychological deficits, and depression on social function in patients with epilepsy (PWE) was analyzed. A brief cognitive screening test (EpiTrack) and an estimation of the last 6 months' cumulative seizure severity (Chalfont seizure severity scale) were performed, and questionnaires on subjectively perceived cognitive deficits (c.I.-Skala), anxiety (State-Trait Anxiety Inventory, STAIX1 and STAIX2), depression (Self Rating Depression Scale, SDS), and social function (Soziale Aktivität Selbstbeurteilungsskala, SASS) were completed. Forty PWE (aged 41.8 years, SD 16; 24 female, 16 male) were analyzed. Thirty-eight point 5 percent had a score signifying depression in the SDS; 20% had a pathological result in at least one of the anxiety scores. The ANOVA revealed that only anxiety as a trait symptom (STAIX2) had a significant influence on social function apart from the other factors (p<0.004). Additionally there was a trend for a significant influence of depressive symptoms (SDS) on social functioning (p=0.093). Symptoms of anxiety impair the social function of patients with epilepsy apart from depression, cognitive function, and seizure severity. They should be taken into account in the treatment of patients with epilepsy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Social function

Mesh:

Year:  2016        PMID: 26900773     DOI: 10.1016/j.yebeh.2015.10.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

Review 1.  Assessment of Anxiety in Patients With Epilepsy: A Literature Review.

Authors:  Raphael Rauh; Andreas Schulze-Bonhage; Birgitta Metternich
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

2.  Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study.

Authors:  Haoyue Zhu; Xuejun Deng; Li Feng; Yajun Lian; Xiong Han; Zhenli Guo; Yulan Gou; Yuanmin Du; Longshan Xie; Dongai Yao; Yonghong Liu; Qiang Wu; Song Lan; Kaisheng Liu; Peiyan Zhan; Xiahong Wang; Jingxia Dang; Yunqi Hou; Keqiang Chen; Yulan Zhu; Yuliang Shi; Yunli Yu; Bo Xiao; Suiqiang Zhu; Hongmei Meng
Journal:  CNS Neurosci Ther       Date:  2022-04-15       Impact factor: 7.035

3.  Psychiatric Comorbidities in Epilepsy.

Authors:  Carlos Arteaga Rodríguez; Mariana Menine Kubis; Carlos Bruno Teixeira Arteaga; Otto Jesus Hernandez Fustes
Journal:  J Epilepsy Res       Date:  2022-06-30

4.  Clinical Study on Electronic Medical Neuroelectric Stimulation Based on the Internet of Things to Treat Epilepsy Patients with Anxiety and Depression.

Authors:  Bo Zhang; Weijie Wang; Shenguo Wang; Shaoping Li; Mingchao Liu; Lantian Wang; Caijun Yang
Journal:  J Healthc Eng       Date:  2021-03-17       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.